Efficacy of mild hypothermia combined with monosialotetrahexosyl ganglioside in the treatment of neonatal hypoxic-ischemic encephalopathy and its effect on serum inflammation, GFAP and NSE levels

Background and purpose Analyze the efficacy of mild hypothermia combined with monosialotetrahexosyl ganglioside in the treatment of neonatal hypoxic ischemic encephalopathy (HIE) and its effect on serum inflammation and serum glial fibrillary acidic protein (GFAP),effect of neuron specific enolase (NSE) levels. 98 children with HIE admitted to our hospital from June 2020 to June 2024 were randomly divided into a control group and an observation group with 49 cases in each group. On the basis of routine oxygen inhalation treatment, the control group was treated with monosialotetrahexosyl ganglioside, and the observation group was treated with mild hypothermia on the basis of the control group. After 14 days of treatment, the treatment efficacy and functional recovery time [muscle tone, sucking ability, primitive reflexes] were compared between the two groups. The levels of serum inflammation-related indicators [high-sensitivity C-reactive protein (hs-CRP), micro-molecule ribonucleic acid-384 (miR-384)] and nerve damage markers [GFAP, NSE, B lymphomas-2 (Bcl-2)] were compared between the two groups before and after treatment. After 14 days of treatment, compared with the control group, the total effective rate of treatment in the observation group was significantly higher (P<0.05). The recovery time of muscle tension, sucking ability, and original reflexes was significantly shorter (P<0.05). After 14 days of treatment, hs-CRP, GFAP, NSE, and Bcl-2 decreased in both groups, and compared with the control group, the levels in the observation group were lower (P<0.05) . The levels of miR-384 increased, and compared with the control group, the levels in the observation group were higher (P<0.05). Mild hypothermia combined with monosialotetrahexosyl ganglioside is effective in treating children with HIE. It can reduce their inflammation level, relieve nerve damage, and be conducive to the recovery of muscle tone and other functions.

Publication Details

Journal
International Journal of Frontiers in Medicine
Published
2025-01-01
DOI
https://doi.org/10.25236/ijfm.2025.070203
Primary Topic
Neonatal and fetal brain pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of mild hypothermia combined with monosialotetrahexosyl ganglioside in the treatment of neonatal hypoxic-ischemic encephalopathy and its effect on serum inflammation, GFAP and NSE levels

International Journal of Frontiers in Medicine
Neonatal and fetal brain pathology
article

Efficacy of mild hypothermia combined with monosialotetrahexosyl ganglioside in the treatment of neonatal hypoxic-ischemic encephalopathy and its effect on serum inflammation, GFAP and NSE levels

article en

Abstract

Background and purpose Analyze the efficacy of mild hypothermia combined with monosialotetrahexosyl ganglioside in the treatment of neonatal hypoxic ischemic encephalopathy (HIE) and its effect on serum inflammation and serum glial fibrillary acidic protein (GFAP),effect of neuron specific enolase (NSE) levels. 98 children with HIE admitted to our hospital from June 2020 to June 2024 were randomly divided into a control group and an observation group with 49 cases in each group. On the basis of routine oxygen inhalation treatment, the control group was treated with monosialotetrahexosyl ganglioside, and the observation group was treated with mild hypothermia on the basis of the control group. After 14 days of treatment, the treatment efficacy and functional recovery time [muscle tone, sucking ability, primitive reflexes] were compared between the two groups. The levels of serum inflammation-related indicators [high-sensitivity C-reactive protein (hs-CRP), micro-molecule ribonucleic acid-384 (miR-384)] and nerve damage markers [GFAP, NSE, B lymphomas-2 (Bcl-2)] were compared between the two groups before and after treatment. After 14 days of treatment, compared with the control group, the total effective rate of treatment in the observation group was significantly higher (P<0.05). The recovery time of muscle tension, sucking ability, and original reflexes was significantly shorter (P<0.05). After 14 days of treatment, hs-CRP, GFAP, NSE, and Bcl-2 decreased in both groups, and compared with the control group, the levels in the observation group were lower (P<0.05) . The levels of miR-384 increased, and compared with the control group, the levels in the observation group were higher (P<0.05). Mild hypothermia combined with monosialotetrahexosyl ganglioside is effective in treating children with HIE. It can reduce their inflammation level, relieve nerve damage, and be conducive to the recovery of muscle tone and other functions.

International Journal of Frontiers in MedicineVol. 7(2)
Good health and well-being
Openalex Percentile: Top 86%
Neonatal and fetal brain pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy of mild hypothermia combined with monosialotetrahexosyl ganglioside in the treatment of neonatal hypoxic-ischemic encephalopathy and its effect on serum inflammation, GFAP and NSE levels · International Journal of Frontiers in Medicine (2025) | TGRS Research Map | TGRS